Impact of the Different Preparation Methods to Obtain Autologous Non-Activated Platelet-Rich Plasma (A-PRP) and Activated Platelet-Rich Plasma (AA-PRP) in Plastic Surgery: Wound Healing and Hair Regrowth Evaluation.

A-PRP PRP PRP kit PRP procedures activated PRP autologous platelet-rich plasma non-activated PRP platelet-rich plasma regenerative plastic surgery

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
09 Jan 2020
Historique:
received: 03 12 2019
revised: 25 12 2019
accepted: 08 01 2020
entrez: 16 1 2020
pubmed: 16 1 2020
medline: 2 10 2020
Statut: epublish

Résumé

Autologous therapies using platelet-rich plasma (PRP) need meticulous preparation-currently, no standardised preparation technique exists. Processing Quantitative Standards (PQSs) define manufacturing quantitative variables (such as time, volume and pressure). Processing Qualitative Standards (PQLSs) define the quality of the materials and methods of manufacturing. The aim of this review is to use existing PQSs and PQLs to report the in vivo/in vitro results obtained by using different Kits, that utilise different procedures (classified as Closed-Technique and Opened-Technique) to isolate autologous human activated (AA-PRP) or non-activated PRP (A-PRP). PQSs included the volumes of blood collected as well as the reagents used, the time/gravity of centrifugation, and the duration, temperature and tilt level/speed of centrifugation. PQLSs included the use of Calcium Chloride CaCl

Identifiants

pubmed: 31936605
pii: ijms21020431
doi: 10.3390/ijms21020431
pmc: PMC7014364
pii:
doi:

Substances chimiques

Fibrin 9001-31-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Mol Sci. 2019 Jul 13;20(14):
pubmed: 31337037
J Clin Med. 2019 Sep 18;8(9):
pubmed: 31540446
Curr Med Res Opin. 2005 Aug;21(8):1235-40
pubmed: 16083533
Cartilage. 2013 Oct;4(4):295-312
pubmed: 26069674
Int J Dermatol. 1996 Aug;35(8):539-44
pubmed: 8854147
Adv Skin Wound Care. 2011 Apr;24(4):176-81
pubmed: 21422842
Plast Reconstr Surg. 2008 Nov;122(5):1352-60
pubmed: 18971718
Int J Mol Sci. 2017 Feb 14;18(2):
pubmed: 28216604
Indian J Plast Surg. 2012 May;45(2):193-202
pubmed: 23162216
Biol Res Nurs. 2015 Mar;17(2):152-8
pubmed: 24848975
Am J Sports Med. 2015 Dec;43(12):3062-70
pubmed: 26473014
Clin Dermatol. 1994 Jan-Mar;12(1):19-26
pubmed: 8180941
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Proc Natl Acad Sci U S A. 1975 Aug;72(8):2994-8
pubmed: 1059088
J Craniofac Surg. 2010 May;21(3):900-4
pubmed: 20485077
Sports Health. 2012 Mar;4(2):162-72
pubmed: 23016084
J Thromb Haemost. 2018 Sep;16(9):1895-1900
pubmed: 30099839
World J Plast Surg. 2013 Jan;2(1):2-5
pubmed: 25489497
Stem Cell Investig. 2017 Jun 27;4:58
pubmed: 28725654
J Tissue Eng Regen Med. 2017 Aug;11(8):2398-2410
pubmed: 27074878
Cell Prolif. 2009 Apr;42(2):162-70
pubmed: 19250293
Bioethics. 2000 Apr;14(2):158-72
pubmed: 11765763
Vox Sang. 2009 Aug;97(2):110-8
pubmed: 19392780
J Cutan Aesthet Surg. 2014 Oct-Dec;7(4):189-97
pubmed: 25722595

Auteurs

Pietro Gentile (P)

Plastic and Reconstructive Surgery, Surgical Science Department, University of Rome "Tor Vergata", 00179 Rome, Italy.

Claudio Calabrese (C)

San Rossore Clinic, Breast Unit Department, 56122 Pisa, Italy.

Barbara De Angelis (B)

Plastic and Reconstructive Surgery, Surgical Science Department, University of Rome "Tor Vergata", 00179 Rome, Italy.

Laura Dionisi (L)

Dionisi Law Firm, 00133 Rome, Italy.

Jacopo Pizzicannella (J)

Ss. Annunziata Hospital, ASL02 Lanciano-Vasto Chieti, 66100 Chieti, Italy.

Ashutosh Kothari (A)

Head of Breast Surgery Unit, Guy's Hospital, Guy's and St. Thomas' NHS Foundation Trust, London SE1 9RT, UK.

Domenico De Fazio (D)

Institute of Plastic Surgery, Galeazzi Hospital, 20122 Milan, Italy.

Simone Garcovich (S)

Institute of Dermatology, Fondazione Policlinico Gemelli IRCSS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH